Latest Articles

  • New Alzheimer’s Medications

    January 27, 2025

    Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shared her excitement with the Daily Express about the groundbreaking new Alzheimer’s drugs that are now available […]

  • Re:Cognition Health Brings Groundbreaking Alzheimer’s Treatment Kisunla™ to Private Patients

    January 27, 2025

    Press Office

    Re:Cognition Health is proud to announce the launch of Kisunla™ (donanemab), a revolutionary Alzheimer’s treatment, for private patients at our specialist clinics. This follows the success of […]

Help us make a difference in cognitive health

Sign Up Now